Skip to main content

Table 1 Published studies on colorectal lymphoma

From: Primary lymphoma of the colon: report of two cases and review of literature

Author (year) [Ref.]

Number of cases

Histological type (WHO)

Treatment modality

Survival

Bairey et al. 2006 [3]

17

Diffuse large B cell lymphoma

Multimodality, 9

Chemotherapy, 6

Surgery, 2

Median, 44 months

Musallam et al. 2010 [26]

9

Diffuse large B cell lymphoma, 6

Burkitt lymphoma, 3

Multimodality, 5

Chemotherapy, 3

Surgery, 1

Median, 25 months

Wong and Eu 2006 [11]

14

Diffuse large B cell lymphoma

Multimodality, 11

Surgery, 3

5-year overall survival, 57%

Kim et al. 2005 [27]

95

B cell, 82.1%

T cell, 17.9%

Multimodality, 57

Chemotherapy, 23

Surgery, 15

5-year overall survival, 55.2%

Pandey et al. 2002 [28]

8

Large cell, 3

Small cell, 1

Mix large and small, 3

Lymphoblastic, 1

Surgery with adjuvant therapy in all

66% 4 years

Auger et al. 1990 [29]

22

Diffuse histiocytic lymphoma

Multimodality, 14

Surgery, 8

N/A

Zighelboim and Larson 1994 [30]

15

 

Multimodality, 3

Chemotherapy, 12

5-year survival, 27%

Gonzalez et al. 2008 [5]

15

 

Multimodality, 12

Surgery, 3

Median survival, 60 months

Doolabh et al. 2000 [2]

7

Small non-cleaved, 5

Large cell, 2

Multimodality, 6

Surgery, 1

N/A

Cho et al. 1997 [31]

23

 

Multimodality, 14

Chemotherapy, 4

Surgery, 3

10-year survival, 61%

Fan et al. 2000 [10]

37

High grade, 29

Intermediate and low grade, 8

Multimodality, 22

Chemotherapy, 2

Surgery, 13

Median survival, 24 months

Stanojevic et al. 2008 [14]

24

 

Multimodality, 20

Surgery, 4

Median survival, 41.9%

Busch et al. 1994 [32]

19

 

Multimodality, 14

Chemotherapy, 4

Surgery, 1

Median survival, 45 months

Zinzani et al. 1997 [1]

32

High grade, 26

Low grade, 6

Multimodality, 22

Chemotherapy, 10

5-year overall survival, 59%

Zhou et al. 2011 [25]

32

B cell, 22 (DLBCL most common)

T cell, 10

B cell, multimodality (22)

T cell, surgery (8)

B cell DFS at 55 months, 88.2%

T cell, 3 alive after 23 months

She et al. 2011 [33]

10

B cell, 8

Burkitt, 1

Mantle cell, 1

Surgery, 7

Chemotherapy, 3

Median survival

Surgery, 17 months

Chemotherapy, 13 months

Zhai et al. 2012 [22]

46

B cell origin, 35

T cell, 11

 

5-year survival, 64.2%

Progression-free survival, 49.3%

Pascual et al. 2013 [34]

7

Diffuse large B cell lymphoma, 6

Follicular lymphoma, 1

Multimodality, 2

Chemotherapy, 2

Surgery, 3

N/A

Huang et al. 2013 [35]

52

Diffuse large B cell lymphoma, 64.4%

Multimodality, 43

Chemotherapy, 9

5-year survival, 71%

Tevlin et al. 2015 [36]

11

Diffuse large B cell lymphoma

Multimodality, 9

Chemotherapy,  1

Radiotherapy alone, 1

Median event-free survival, 10 months